Global contract development and manufacturing organization for radiotherapeutics.
Location: Canada, Ontario, Hamilton
Employees: 51-200
Total raised: $90M
Founded date: 2021
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.06.2023 | - | $90M | - |
Mentions in press and media 12
| Date | Title | Description |
| 05.09.2026 | AtomVie Global Radiopharma Celebrates the Grand Opening of its New State-of-the-Art Radiopharmaceutical Manufacturing Facility in Hamilton, Ontario | HAMILTON, ON, Sept. 5, 2026 /PRNewswire/ - AtomVie Global Radiopharma (AtomVie), a leading global Contract Development and Manufacturing Organization (CDMO) in the radiopharmaceutical industry, today celebrated the Grand Opening of its new ... |
| 08.07.2026 | Genesys University Seed Fund Holds First Close With Over $30 Million In Commitments | The University of Toronto, McMaster University, Venture Ontario, and Genesys Capital announced the creation of a new early-stage life sciences venture capital fund. The Genesys University Seed Fund has held a first close representing over $... |
| 24.02.2026 | AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics' Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01) | HAMILTON, ON, Feb. 24, 2026 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first patient in Radiopharm Theranostics' First-in-Huma... |
| 06.12.2024 | Transforming Industries: The Rise of Radiopharmaceuticals and Plastic Recycling Technologies | In the world of healthcare and environmental sustainability, two sectors are making waves: radiopharmaceuticals and plastic recycling. Both are crucial in addressing modern challenges. One focuses on healing, while the other aims to save ou... |
| 05.12.2024 | AtomVie Global Radiopharma Appoints Dr. Pratibhash Chattopadhyay as Chief Business Officer to Accelerate Growth and Strengthen Leadership | HAMILTON, ON, Dec. 5, 2024 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, is pleased to announce the appointment of Dr. Pratibhash (Bosh) Chattopadhyay as Chief Business Officer. Dr. Chattop... |
| 16.10.2024 | AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and Manufacture 177Lu-BetaBart Radioantibody for Treatment of Multiple Solid Tumors | HAMILTON, ON, Oct. 16, 2024 /PRNewswire/ -- AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), has entered into an agreement with Radiopharm Ventures (RV), a Joint... |
| 01.06.2023 | AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout | HAMILTON, ON, June 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A ... |
| 01.06.2023 | AtomVie Global Radiopharma raises over $90M to Complete its New Facility Buildout | HAMILTON, ON /CNW/ – AtomVie Global Radiopharma Inc. (AtomVie), a global-leading CDMO for the GMP manufacturing and worldwide distribution of radiopharmaceuticals, today announced the closing of its Tranche 2 Series A financing led by its c... |
| 01.03.2023 | AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario | TORONTO, March 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facilit... |
| 25.08.2022 | AtomVie Global Radiopharma Closes Series A Financing with Avego | AtomVie Global Radiopharma, an Hamilton, ON, Canada-based Contract Development and Manufacturing Organization for the GMP manufacturing and distribution of clinical and commercial radiopharmaceuticals, raised an undisclosed amount in Series... |
Show more